Publikasi

No one’s sure if synthetic mirror life will kill us all

For four days in February 2019, some 30 synthetic biologists and ethicists hunke...

Novel Targets for Complex Cancer Revealed by Genetic Re...

By tracking gene regulation in single cells over time, PerturbFate can systemati...

Biopharma Adopting AI Despite Remaining GMP Compliance ...

AI is streamlining and accelerating process development and manufacturing, but m...

iPSC-Based Manufacture vs. Autologous Model Production ...

Decoupling production from the patient and stem cell donors via a universal mast...

Ultra- and Diafiltration Clear Leachables Effectively

A new study reveals that ultrafiltration and diafiltration can remove over 98% o...

Digital Twin Process Could Slash Microbial Protein Costs

A digital twin of a fully continuous automated manufacturing process could slash...

Unlocking access to preventive oral care in Ireland

Donna Paton explores the role of dental hygienists in improving oral health acro...

BIO Launches ‘Fight of Our Lives’: The Real Stories, Po...

At some point in our lives, many of us will find ourselves in a health fight we ...

AI scribes and documentation time: a ‘modest’ reduction

AI scribes can reduce documentation time among clinicians, a new study found. Re...

Rubicon Research acquires 85% stake in Arinna Lifesciences

Transaction valued at INR 200 crore to expand presence in CNS therapies and dom...

Adcendo secures $75m in Series C funding for ADC develo...

The financing will support Adcendo’s ongoing advancement of its first-in-class a...

Lilly to acquire CrossBridge Bio for up to $300m

The acquisition includes the lead candidate CBB-120, a dual-payload antibody-dru...

MSN Laboratories launches SEMABEST semaglutide in India...

Product priced lower than innovator drug and introduced for type 2 diabetes tre...

Aurigene and Alveus Therapeutics advance collaboration ...

Partnership supports drug discovery programmes for obesity and metabolic diseas...

From competence to mastery: preparing for advanced impl...

Brighton and Sussex Medical School explains how Modules 5 and 6 of its Postgradu...

Orbicular, Gland Pharma and Apotex secure US FDA approv...

ANDA approval with CGT designation grants six-month exclusivity for parenteral ...